Sex Differences in Circulating Biomarkers of Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background Differences in proteomic profiles between men and women may provide insights into the biologic pathways that contribute to known sex differences in cardiovascular disease (CVD). Objectives To investigate sex differences in circulating biomarkers representative of biologic pathways implicated in the development of CVD among Framingham Heart Study participants. Methods We measured 71 circulating CVD protein biomarkers in 7184 participants (54% women, mean age 49). Multivariable models were used to evaluate the associations of sex, menopause and hormone status with biomarkers. Cox models were used to examine whether sex modified the association of biomarkers with incident CVD. Results Of 71 biomarkers examined, 61 (86%) differed significantly between men and women, of which 37 were higher in women (including adipokines and inflammatory markers such as leptin and CRP) and 24 were higher in men (including fibrosis and platelet markers such as MMP8 and TIMP1, FDR q<0.05 for all). Sex differences in biomarker profiles were most pronounced between pre-menopausal women vs men, with attenuated sex differences among post-menopausal women not taking hormone replacement therapy. Sex modified the association of specific biomarkers with incident CVD, including CD14 and ApoB (Pinteraction <0.05 for all). Conclusions In a predominantly Caucasian population, we identified widespread sex differences in circulating biomarkers that reflect distinct pathways implicated in CVD including inflammation, adiposity, fibrosis, and platelet homeostasis. Menopause and hormone status accounted for some but not all the observed sex differences. Further investigation into factors underlying sex-based differences may provide mechanistic insight into CVD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065 · cited 1×
“Taken together, these findings underscore that sex differences in CVD are complex and cannot be explained by sex hormones alone (33).”
BackgroundGrodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063
Race and Gender Differences in C-Reactive Protein Levels
Khera, A., McGuire, D. K., Murphy, S. A., Stanek, H. G., Das, S. R., Vongpatanasin, W., Wians, F. H., Grundy, S. M., & de Lemos, J. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.051 · Cited by 773
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., et al. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.05.018 · Cited by 499 · cited 1×
“(4–6) In this context, it has been proposed that inflammation, metabolic dysregulation, and adiposity contribute more significantly to the pathophysiology of CVD in women compared with men.(4,5) Although the exact mechanisms are ill defined, sex hormones have been implicated as prior observational studies reveal an in…”
BackgroundSelf-citationTHOMPSON, A., & DANESH, J. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01644.x · Cited by 252 · cited 1×
“ApoB is a surface protein on atherogenic lipoproteins, primarily LDL, and has previously been associated with CHD in both men and women (37,38) although plasma levels of ApoB are higher in men and post-menopausal women(39).”
BackgroundInfluence of sex and hormone status on circulating natriuretic peptides
Lam, C. S. P., Cheng, S., Choong, K., Larson, M. G., Murabito, J. M., Newton-Cheh, C., Bhasin, S., McCabe, E. L., Miller, K. K., Redfield, M. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.042 · Cited by 181
Self-citation
Cited by
Sex differences in heart failure
Lam, C. S. P., Arnott, C., Beale, A. L., Chandramouli, C., Hilfiker-Kleiner, D., Kaye, D. M., Ky, B., Santema, B. T., Sliwa, K., & Voors, A. A. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz835 · Cited by 802
Sorimachi, H., Obokata, M., Takahashi, N., Reddy, Y. N. V., Jain, C. C., Verbrugge, F. H., Koepp, K. E., Khosla, S., Jensen, M. D., & Borlaug, B. A. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa823 · Cited by 183
Matters of the heart: Cellular sex differences
Walker, C. J., Schroeder, M. E., Aguado, B. A., Anseth, K. S., & Leinwand, L. A. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.010 · Cited by 74
Schuermans, A., Pournamdari, A. B., Lee, J., Bhukar, R., Ganesh, S., Darosa, N., Small, A. M., Yu, Z., Hornsby, W., Koyama, S., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00567-0 · Cited by 71
“To gain insights into biological pathways associated with the identified proteins, we carried the 820 observed protein–disease associations forward for pathway enrichment analysis using the Gene Ontology resource 16 via Enrichr 17 .”
InfluentialA framework for developing sex-specific engineered heart models
Lock, R., Al Asafen, H., Fleischer, S., Tamargo, M., Zhao, Y., Radisic, M., & Vunjak-Novakovic, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00381-1 · Cited by 50
Metadata
- Authors
- Lau, E. S., Paniagua, S. M., Guseh, J. S., Bhambhani, V., Zanni, M. V., Courchesne, P., Lyass, A., Larson, M. G., Levy, D., & Ho, J. E.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 74
- Issue
- 12
- Pages
- 1543-1553
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2973799453
- Cited by
- 158
- References
- 7
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.